Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs

被引:3
作者
Blaess, Markus [1 ]
Csuk, Rene [2 ]
Schaetzl, Teresa [1 ]
Deigner, Hans-Peter [1 ,3 ,4 ]
机构
[1] Furtwangen Univ, Inst Precis Med, Med & Life Sci Fac, Jakob Kienzle Str 17, D-78054 Villingen Schwenningen, Germany
[2] Martin Luther Univ Halle Wittenberg, Organ Chem, Kurt Mothes Str 2, D-06120 Halle, Saale, Germany
[3] Fraunhofer Inst IZI, EXIM Dept, Schillingallee 68, D-18057 Rostock, Germany
[4] Tuebingen Univ, Fac Sci, Morgenstelle 8, D-72076 Tubingen, Germany
关键词
atopic dermatitis; fatty acid elongation; ELOVL; lysosome; cutaneous adverse effects; ceramide; basic therapy; lysosomotropism; AGEP; eczema; GENERALIZED EXANTHEMATOUS PUSTULOSIS; ACYL-COA SYNTHETASE; STRATUM-CORNEUM; LIPID ORGANIZATION; BIOPHYSICAL PROPERTIES; OXIDATIVE STRESS; BARRIER FUNCTION; LINOLEIC-ACID; CERAMIDE; SKIN;
D O I
10.3390/ijms25179344
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atopic dermatitis (AD) is a common inflammatory skin disease, in particular among infants, and is characterized, among other things, by a modification in fatty acid and ceramide composition of the skin's stratum corneum. Palmitic acid and stearic acid, along with C16-ceramide and 2-hydroxy C16-ceramide, occur strikingly in AD. They coincide with a simultaneous decrease in very long-chain ceramides and ultra-long-chain ceramides, which form the outermost lipid barrier. Ceramides originate from cellular sphingolipid/ceramide metabolism, comprising a well-orchestrated network of enzymes involving various ELOVLs and CerSs in the de novo ceramide synthesis and neutral and acid CERase in degradation. Contrasting changes in long-chain ceramides and very long-chain ceramides in AD can be more clearly explained by the compartmentalization of ceramide synthesis. According to our hypothesis, the origin of increased C16-ceramide and 2-hydroxy C16-ceramide is located in the lysosome. Conversely, the decreased ultra-long-chain and very long-chain ceramides are the result of impaired ELOVL fatty acid elongation. The suggested model's key elements include the lysosomal aCERase, which has pH-dependent long-chain C16-ceramide synthase activity (revaCERase); the NADPH-activated step-in enzyme ELOVL6 for fatty acid elongation; and the coincidence of impaired ELOVL fatty acid elongation and an elevated lysosomal pH, which is considered to be the trigger for the altered ceramide biosynthesis in the lysosome. To maintain the ELOVL6 fatty acid elongation and the supply of NADPH and ATP to the cell, the polyunsaturated PPARG activator linoleic acid is considered to be one of the most suitable compounds. In the event that the increase in lysosomal pH is triggered by lysosomotropic compounds, compounds that disrupt the transmembrane proton gradient or force the breakdown of lysosomal proton pumps, non-HLA-classified AGEP may result.
引用
收藏
页数:30
相关论文
共 132 条
[1]   Purification and characterization of 1-O-acylceramide synthase, a novel phospholipase A2 with transacylase activity [J].
Abe, A ;
Shayman, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :8467-8474
[2]   Making a diagnosis in severe cutaneous drug hypersensitivity reactions [J].
Ardern-Jones, Michael R. ;
Mockenhaupt, Maja .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (04) :283-293
[3]   Glucosylceramidases and malignancies in mammals [J].
Astudillo, Leonardo ;
Therville, Nicole ;
Colacios, Celine ;
Segui, Bruno ;
Andrieu-Abadie, Nathalie ;
Levade, Thierry .
BIOCHIMIE, 2016, 125 :267-280
[4]   Topical Corticosteroid-Induced Skin Atrophy: A Comprehensive Review [J].
Barnes, Laurent ;
Kaya, Gurkan ;
Rollason, Victoria .
DRUG SAFETY, 2015, 38 (05) :493-509
[5]   Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease [J].
Bassaganya-Riera, J ;
Reynolds, K ;
Martino-Catt, S ;
Cui, YZ ;
Hennighausen, L ;
Gonzalez, F ;
Rohrer, J ;
Benninghoff, AU ;
Hontecillas, R .
GASTROENTEROLOGY, 2004, 127 (03) :777-791
[6]   Lipid abnormalities in atopic skin are driven by type 2 cytokines [J].
Berdyshev, Evgeny ;
Goleva, Elena ;
Bronova, Irina ;
Dyjack, Nathan ;
Rios, Cydney ;
Jung, John ;
Taylor, Patricia ;
Jeong, Mingeum ;
Hall, Clifton F. ;
Richers, Brittany N. ;
Norquest, Kathryn A. ;
Zheng, Tao ;
Seibold, Max A. ;
Leung, Donald Y. M. .
JCI INSIGHT, 2018, 3 (04)
[7]   Atopic dermatitis: an expanding therapeutic pipeline for a complex disease [J].
Bieber, Thomas .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (01) :21-40
[8]   Determination of ceramides and diglycerides by the diglyceride kinase assay [J].
Bielawska, A ;
Perry, DK ;
Hannun, YA .
ANALYTICAL BIOCHEMISTRY, 2001, 298 (02) :141-150
[9]   Topical use of amitriptyline and linoleic acid to restore ceramide rheostat in atopic dermatitis lesions - a case report [J].
Blaess, M. ;
Wenzel, F. ;
Csuk, R. ;
Deigner, H-P .
PHARMAZIE, 2019, 74 (09) :563-565
[10]   Drug triggered pruritus, rash, papules, and blisters - is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin? [J].
Blaess, Markus ;
Kaiser, Lars ;
Sommerfeld, Oliver ;
Csuk, Rene ;
Deigner, Hans-Peter .
LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)